Categories
All-en All-id Covid-19-en Covid-19-id doc-library-en doc-library-id News-en News-id Reports-en Reports-id

WHO Publishes Covid-19 Self-Test Guide

March 10, 2022 On March 9, 2022, WHO published its own COVID-19 Test Guide. This guidance is motivated by the realization that timely and accurate diagnostic testing for SARS-CoV-2 is an essential part of a comprehensive COVID-19 response strategy. Rapid tests to detect the SARS-CoV-2 antigen can be carried out by individuals where they collect…

Categories
All-en All-id Covid-19-en Covid-19-id News-en News-id

WHO Recommends Two New Drugs to Treat COVID-19

WHO has recommended two new drugs for COVID-19, providing yet more options for treating the disease. The extent to which these medicines will save lives depends on how widely available and affordable they will be. The first drug, baricitinib, is strongly recommended for patients with severe or critical COVID-19. It is part of a class…

Categories
All-en All-id Covid-19-en Covid-19-id Hiv-en Hiv-id

Anak dengan HIV di tengah pandemi

One of the groups most affected during the COVID-19 pandemic is children. Even outside of the pandemic period, children have vulnerabilities: vulnerable to illness, vulnerable to violence, and vulnerable to being mistreated by adults. In the framework of World AIDS Day 2021, the Health Collaborative Center collaborated with Lentera Anak Pelangi and Yayasan Peduli Hati…

Categories
All-en Covid-19-en doc-library-en Hiv-en Reports-en

Assessing the impact of COVID-19 on access to health services for key populations and people living with HIV in Indonesia

The study was conducted in October 2020 in Jakarta with 15 respondents from Jakarta and Bekasi. This study involves a participatory approach to try to understand the impact of Covid-19 on nine specific indicators, namely: HIV test; Treatment; HIV-related services (drug harm reduction, maternal and child health, STIs, etc.); Employment and income; Food security; Safe…

Categories
All-en Covid-19-en doc-library-en

Current RT-PCR test fee – August 2021

Based on CIRCULAR LETTER NUMBER: HK.02.02/I/2845/2021 CONCERNING THE HIGHEST RATE LIMIT FOR RESERVE TRANSCRIPTION POLYMERASE CHAIN REACTION (RT-PCR) examination, the following is the highest Tariff Limit for the latest RT-PCR examination: a. For RT-PCR examination in Java and Bali, Rp. 495.000,-b. For RT-PCR examination outside Java and Bali, Rp. 525.000,- Note: The highest tariff limit…